Sano blog | rare disease (5)

precision medicine rare disease genetic testing

Personalized medicine for DMD: Genetics to treatment

Duchenne muscular dystrophy (DMD) is an inherited disorder that is characterized by progressive muscle degeneration, leading to loss of function and premature d...

biomarkers precision medicine rare disease

How precision medicine is advancing myasthenia gravis treatment

Myasthenia gravis (MG) is a chronic neuromuscular disorder (NMD) that is characterized by muscle fatigue and weakness. It is considered a rare disease, affectin...

Podcast episode cover with Frank Gleeson

rare disease podcast recap

Podcast recap: Frank Gleeson on targeting muscle regeneration to tackle Duchenne muscular dystrophy

On a recent episode of The Genetics Podcast, Patrick spoke with Frank Gleeson, co-founder and CEO of Satellos Bioscience, a Canadian biotech pioneering a regene...

precision medicine rare disease genetic testing

Understanding CRISPR evolution: A decade of progress, a breakthrough, and what’s next

News of a ‘CRISPR baby’ broke this week, almost seven years after the first CRISPR baby scandal unleashed a media frenzy and years of ethical debates. But this ...

press precision medicine rare disease

Partnering to unlock the next chapter in lupus research

We’re proud to share that Sano Genetics plays a key role in the newly announced Lupus Nexus Foundational Analyses, a groundbreaking initiative led by the Lupus ...

patient recruitment rare disease

Clinical trial recruitment for rare disease: AI + JIT

Clinical trial recruitment remains one of the most persistent bottlenecks in drug development. Across therapeutic areas, trials routinely face delays, cost over...

rare disease patient engagement

Modernizing rare disease trials with patient-centered innovation

While there have been significant strides in the development of drugs for rare diseases over the past few decades, only 5% of rare diseases have FDA-approved tr...

precision medicine rare disease podcast recap

Podcast recap: Kent Rogers on building a path for N-of-1 therapies and transforming rare disease treatment

In a recent episode of The Genetics Podcast, Patrick spoke with Kent Rogers, CEO of EveryONE Medicines, about the future of individualized medicines, especially...

rare disease genetic testing podcast recap

Podcast recap: Matt Burgess on genetic counseling, ethics in rare disease, and demystifying genetics

In the most recent episode of The Genetics Podcast, Patrick sits down with fellow podcaster and genetic counselor Matt Burgess. Matt is the host of Demystifying...

precision medicine genetic epidemiology rare disease

Building better data ecosystems for rare and ultra-rare conditions

In rare and ultra-rare diseases, data availability is one of the most significant constraints in research and drug development. With thousands of rare condition...

Clinical research blog